Usted buscó: evaluerbara (Sueco - Inglés)

n: patienter evaluerbara för svar
n: response-evaluable patients

totalt 218 patienter var evaluerbara för svar.
a total of 218 patients were evaluable for response.

totalt 74 evaluerbara patienter fick dexametason tillsammans med velcade.
a total of 74 evaluable patients were administered dexamethasone in combination with velcade.

säkerhetsanalysen av 25 evaluerbara patienter reflekterade den säkerhetsprofil som förväntades.
safety analysis of 25 evaluable patients reflected a safety profile as expected.

overall response rate var 6,8 % hos evaluerbara patienter och median för responsduration var 26,1 veckor.
the overall response rate was 6.8% in the evaluable patients, and the median duration of response was 26.1 weeks.

effektresultat hos 229 evaluerbara patienter visade en total respons (normalisering av plasmaurinsyranivåer) på 96,1%.
efficacy results on 229 evaluable patients showed an overall response rate (normalization of plasma uric acid levels) of 96.1%.

effektanalys i studie 3090a1-301-ww baserades på 22 evaluerbara pediatriska patienter på profylaxregim inkluderande 4 patienter på vid behovsbehandling som tvärt ändrades till profylaxbehandling.
efficacy analysis in study 3090a1-301-ww was based on 22 evaluable paediatric subjects on prophylaxis regimen including 4 on-demand patients who shortly changed to prophylaxis.

medianåldern på den evaluerbara populationen var 62 år (46 % var minst 65 år gamla), 61 % var män och 100 % vita.
the median age of the efficacy evaluable population was 62 years (46 % were at least 65 years old), 61 % male and 100 % white.

vid omfattande periodisk utvärdering av ekg vid tidpunkter motsvarande terapeutiska eller högre exponeringar utvecklade ingen patient, vare sig i den evaluerbara eller i itt- populationen, någon qtc- förlängning som bedömdes som ” allvarlig ” (dvs ≥ grad 3 enligt ctcae version 3).
using comprehensive serial ecg assessments at times corresponding to either therapeutic or greater than therapeutic exposures, none of the patients in the evaluable or itt populations were observed to develop qtc prolongation considered as “ severe” (i. e. equal to or greater than grade 3 by ctcae version 3.0).